Syndax Announces Participation in February Investor Conferences
Press Releases
Syndax Pharmaceuticals, Inc.  
January 30, 2025

Syndax Announces Participation in February Investor Conferences

WALTHAM, Mass., Jan. 30, 2025 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive

avatar profile Olean Times Herald

Olean Times Herald


Local & Social